HomeServicesProduct ServicesEmprove® ProgramEmprove® Dossiers for Cell Culture Media in Upstream Processes

Emprove® Dossiers for Cell Culture Media in Upstream Processes

Illustration of scientist focused on quality of final drug product, supported by Emprove® CCM portfolio

Cell culture media (CCM) drive the productivity of upstream processes and help ensure critical quality attributes of the final drug product. Because of this critical role in manufacturing, along with increased regulatory focus on raw materials, it is recommended that media be included in drug product risk assessments.1,2

To ease the burden of collecting the extensive information needed for a thorough assessment, Cellvento® CHO cell culture media are included in our Emprove® Program.

Subscribe to Emprove® Suite

Dossiers that support upstream productivity, risk assessment, and product quality

As part of the Emprove® Program, cell culture media in our Emprove® CCM portfolio include comprehensive dossiers that facilitate your process optimization, risk assessment, and quality efforts.

Target Emprove® Dossier Availability for Cellvento® Media

Emprove® Suite: 24/7 online access to all our dossiers

Unlock all the benefits of the Emprove® Program by subscribing to our Emprove® Suite. Available exclusively for subscribers, all dossiers of the entire Emprove® portfolio can be accessed at your convenience.

  • Subscriptions of one, two, or five years
  • 24/7 online access
  • Constantly updated
  • Optimized searches

To subscribe today, simply complete and submit the reply form below after reading our Emprove® terms and conditions.


Related Product Resources

Tool: Risk Mitigation and Quality Requirements: Support for Bioprocesses



References

1.
Sept. 2019. Raw Material Risk Assessments – A Holistic Approach to Raw Material Risk Assessments through Industrial Collaboration. BioPhorum.
2.
Dec. 2018. Management and Control of Raw Materials Used in the Manufacture of Biological Medicinal Products and ATMPs. European Biopharmaceutical Enterprises.